|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM166981575 |
| 003 |
DE-627 |
| 005 |
20231223111940.0 |
| 007 |
tu |
| 008 |
231223s2007 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0557.xml
|
| 035 |
|
|
|a (DE-627)NLM166981575
|
| 035 |
|
|
|a (NLM)17146803
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Shammas, Christos
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a NMR structure of the peptidyl transferase RNA inhibitor antibiotic amicetin
|
| 264 |
|
1 |
|c 2007
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 13.03.2007
|
| 500 |
|
|
|a Date Revised 29.01.2022
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright (c) 2006 John Wiley & Sons, Ltd.
|
| 520 |
|
|
|a In this communication, we report the solution state NMR structure determination of the peptidyl transferase RNA inhibitor antibiotic amicetin. We have successfully characterised the NMR spectrum of amicetin using a range of homo- and heteronuclear NMR techniques. Using experimental ROE-based distance and 1H--1H scalar coupling derived dihedral angle geometrical constraints as input into the three-dimensional structure determination protocol, we have generated an energy-minimised average structure of the antibiotic. Amicetin adopts a stable well-folded conformation in solution, mediated by a network of hydrogen bonds caused by proton donor and acceptor groups at either end of the molecule. The NMR structure of amicetin shows that the cytosine moiety occupies the critical turn position within the fold, which may be structurally significant for interaction with peptidyl transferase ribosomal RNA. The structure is distinctly different from the published X-ray crystal structure of amicetin in which it adopts a linear, extended chain-like conformation with a number of intermolecular hydrogen bonds. In addition to structure, we have probed the dynamics of amicetin in solution and have observed retarded exchange of the amide proton involved in folding. We have also characterised the ionisation properties of amicetin by carrying out NMR pH titration and measuring the pKa of the primary and tertiary amino groups, 7.27 and 7.52, respectively, which are in agreement with the reported values in literature. Solving the NMR structure of amicetin provides a valuable opportunity to determine the structure of its complex with RNA in solution state
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
7 |
|a Anti-Bacterial Agents
|2 NLM
|
| 650 |
|
7 |
|a Pyrimidine Nucleosides
|2 NLM
|
| 650 |
|
7 |
|a RNA, Ribosomal, 23S
|2 NLM
|
| 650 |
|
7 |
|a amicetin
|2 NLM
|
| 650 |
|
7 |
|a 0909X15C85
|2 NLM
|
| 650 |
|
7 |
|a Peptidyl Transferases
|2 NLM
|
| 650 |
|
7 |
|a EC 2.3.2.12
|2 NLM
|
| 700 |
1 |
|
|a Donarski, James A
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ramesh, Vasudevan
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Magnetic resonance in chemistry : MRC
|d 1985
|g 45(2007), 2 vom: 04. Feb., Seite 133-41
|w (DE-627)NLM098179667
|x 1097-458X
|7 nnns
|
| 773 |
1 |
8 |
|g volume:45
|g year:2007
|g number:2
|g day:04
|g month:02
|g pages:133-41
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 45
|j 2007
|e 2
|b 04
|c 02
|h 133-41
|